{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"abebaf0f6325","filters":{"venue":"Blood and Lymphatic Cancer Targets and Therapy"}},"results":[{"id":"W2772944194","doi":"10.2147/blctt.s132060","title":"Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects","year":2017,"lang":"en","type":"review","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Interleukin-3 receptor; Plasmacytoid dendritic cell; Myeloid leukemia; Medicine; Venetoclax; Immunotherapy; Myeloid; Leukemia; Lymphoma; Oncology; Immunology; Cancer research; Internal medicine; Cancer; Dendritic cell; Immune system; Chronic lymphocytic leukemia","authors":[{"name":"Amy M. Trottier","is_ca":true},{"name":"Sonia Cerquozzi","is_ca":true},{"name":"Carolyn Owen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06908194046716576,"gpt":0.3568258328567061,"spread":0.2877438923895403,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001641152,0.0006935472,0.002107164,0.0002041746,0.0003835117,0.0001841099,0.0001478295,0.0003450736,0.0001045195],"category_scores_gemma":[0.00003010182,0.0004851744,0.0001787222,0.00007069379,0.0003475519,0.00008426263,0.00009326347,0.0002337532,0.000005114228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005904029,"about_ca_system_score_gemma":0.0007092895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007605672,"about_ca_topic_score_gemma":0.00008632637,"domain_scores_codex":[0.9977174,0.0001003954,0.0004129315,0.0008623793,0.0003564258,0.0005504937],"domain_scores_gemma":[0.9986269,0.0001870833,0.0002513749,0.0004372709,0.0001060913,0.0003913019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009675906,0.0002498121,0.000122664,0.02162595,0.0006840899,0.0002764694,0.0007947653,1.331865e-8,0.000008576667,0.0001322019,0.0000636567,0.9759451],"study_design_scores_gemma":[0.005370995,0.0007232636,0.0001807418,0.005567385,0.001127647,0.00319442,0.0001609946,0.00001686826,0.00002388934,0.0001895948,0.9828543,0.0005899135],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002112271,0.9939757,4.391922e-7,0.0004559856,0.0002296538,0.001873618,0.00007009249,0.0000384926,0.00124372],"genre_scores_gemma":[0.001409931,0.9956579,0.00004640287,0.0001119451,0.0009749846,0.000424834,0.00003338071,0.0001098272,0.001230776],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9827906,"threshold_uncertainty_score":0.99976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2498089677","doi":"10.2147/blctt.s84157","title":"Waldenström macroglobulinemia: biology, genetics, and therapy","year":2016,"lang":"en","type":"review","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Stephen's University","funders":"","keywords":"Ibrutinib; Waldenstrom macroglobulinemia; Bruton's tyrosine kinase; Medicine; Lymphoplasmacytic Lymphoma; Rituximab; Oncology; Lymphoma; Macroglobulinemia; CXCR4; Internal medicine; Germline mutation; Cancer research; Immunology; Leukemia; Chronic lymphocytic leukemia; Biology; Mutation; Tyrosine kinase; Genetics; Multiple myeloma; Receptor","authors":[{"name":"Stephen M. Ansell","is_ca":true},{"name":"Jonas Paludo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06055768449692186,"gpt":0.3826594748749941,"spread":0.3221017903780722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003328818,0.0007422174,0.002123016,0.00019662,0.0001875098,0.00009292846,0.0001820779,0.0005849657,0.0004638976],"category_scores_gemma":[0.00002981423,0.0004288202,0.0002382444,0.0001685892,0.0006737959,0.00004756455,0.0001372323,0.0002097452,0.000012877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006116878,"about_ca_system_score_gemma":0.003555362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006218699,"about_ca_topic_score_gemma":0.00002684409,"domain_scores_codex":[0.9972367,0.0001509755,0.0006527964,0.000967082,0.0002806738,0.0007118299],"domain_scores_gemma":[0.9983208,0.00029889,0.0002641594,0.0005542753,0.000111203,0.0004506551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001158165,0.0001131493,0.0001563482,0.003325416,0.001235308,0.00004608295,0.0001218641,1.007642e-8,0.00005600818,0.00008862362,0.0004938384,0.9942476],"study_design_scores_gemma":[0.01883369,0.0004245151,0.00003007216,0.004807313,0.0004781899,0.0009563044,0.000008776453,0.00001031992,0.00004778128,0.0002766657,0.9736188,0.0005075909],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005905116,0.9914724,0.000007961374,0.0003416666,0.0002599964,0.00153596,0.0002023015,0.00005372033,0.0002208935],"genre_scores_gemma":[0.0004443828,0.9958816,0.0002214901,0.0004870822,0.001047613,0.0002842178,0.00008161808,0.0001172986,0.001434661],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.99374,"threshold_uncertainty_score":0.9998164,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052425543","doi":"10.2147/blctt.s44343","title":"MicroRNA dysregulation in B-cell non-Hodgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; microRNA; Hodgkin lymphoma; Immune dysregulation; Cancer research; Biology; Immunology; Genetics; Gene; Immune system","authors":[{"name":"Marco A. Marra","is_ca":true},{"name":"Lim","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005049668615530808,"gpt":0.2192365307887121,"spread":0.2141868621731813,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006492972,0.0001474458,0.0001344189,0.00004532587,0.00005571616,0.00004644761,0.00005408358,0.00009152495,0.00007675295],"category_scores_gemma":[0.000002997527,0.0001302179,0.00003179163,0.00005846698,0.00005484372,0.00001167911,0.00002784582,0.00001303689,0.000002339269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001104233,"about_ca_system_score_gemma":0.00005334974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005117593,"about_ca_topic_score_gemma":0.00004217924,"domain_scores_codex":[0.9992744,0.00002795017,0.0001681184,0.0002826587,0.00006570956,0.000181164],"domain_scores_gemma":[0.9996713,0.000006668711,0.00006832055,0.0001418966,0.0000362596,0.00007553531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00005172016,0.0001520976,0.02009994,0.00003331465,0.0000445293,0.000001171494,0.0001424113,0.00001146776,0.8967842,0.00001525228,0.0003574666,0.08230639],"study_design_scores_gemma":[0.008426144,0.0002291818,0.553516,0.00005097414,0.00003067209,0.00001506642,0.00006354097,0.0007888132,0.4237777,0.0005506774,0.01212626,0.000424952],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9654682,0.03373139,0.0000577252,0.0001681602,0.00005977431,0.0003302025,0.00000761772,0.00000613616,0.0001707512],"genre_scores_gemma":[0.9919143,0.007029563,0.0002381283,0.0003158663,0.0001350034,0.00009246436,0.00003830314,0.00001930992,0.0002170155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5334161,"threshold_uncertainty_score":0.5310133,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}